Novel insect cell line
AssigneeNovavax, Inc.
InventorRobin A. Robinson
Life of this patent
Estimating the term…
Loading patent…
AssigneeNovavax, Inc.
InventorRobin A. Robinson
Estimating the term…
An insect cell line capable of growth in serum-free media and secretion of high levels of recombinant proteins, including virus-like particles, upon infection with recombinant baculoviruses, is provided. Methods involving clonal selection processes, serum-weaning and recombinant protein secretion selection are used to create the insect lines of the invention. This cell line supports replication of baculoviruses, serves as host substrate for baculovirus plaque assays, provides a source of insect proteins, acts as a depot for cell transfection to produce recombinant baculoviruses, and express viral recombinant proteins. Extracellular and intracellular viral recombinant proteins and virus-like particles expressed from this cell line are useful as pharmaceutical compositions, vaccines, or diagnostic reagents.
A cell line comprising a cell that is a clone, derivative, mutant, and/or transfectant of a cell line designated ATCC PTA-4047, wherein the cell upon culture grows continuously and retains the identifying characteristics of the cell line designated ATCC-4047.
A process for making a cell line, comprising the steps of:
The process of claim 16, wherein the enveloped virus and the non-enveloped virus comprises rotavirus, calicivirus, papillomavirus, hepatitis C virus, hepatitis E virus, influenza virus, human immunodeficiency virus, or a combination thereof.
Dependencies are inferred from the claim text.